Instrument Inactif

Communiqués Cadence Pharmaceuticals, Inc.

Actions

US12738T1007

Produits pharmaceutiques

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

Communiqués

28/02/14	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results	PR
17/02/14	Cadence Pharmaceuticals, Inc. : SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. in Connection With the Sale of the Company to Mallinckrodt plc	BU
14/02/14	Cadence Pharmaceuticals, Inc. : SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc.	BU
13/02/14	Cadence Pharmaceuticals, Inc. : INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. and Its Board of Directors in Connection with the Sale of the Company to Mallinckrodt plc -- CADX	BU
13/02/14	Cadence Pharmaceuticals, Inc. : CADENCE INVESTOR ALERT: Faruqi & Faruqi, LLP is Investigating Cadence Pharmaceuticals, Inc. (CADX) in Relation to the Proposed Sale of the Company to Mallinckrodt plc	BU
12/02/14	Cadence Pharmaceuticals, Inc. : SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. - CADX	PR
12/02/14	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Mallinckrodt plc	BU
12/02/14	Cadence Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of Cadence Pharmaceuticals Inc.	PR
12/02/14	Cadence Pharmaceuticals, Inc. : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout	BU
12/02/14	Cadence Pharmaceuticals, Inc. : Harwood Feffer LLP Announces Investigation of Cadence Pharmaceuticals, Inc.	PR
11/02/14	Cadence Pharmaceuticals, Inc. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cadence Pharmaceuticals, Inc. Stockholders	BU
11/02/14	Cadence Pharmaceuticals, Inc. : SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Cadence Pharmaceuticals, Inc. - CADX	PR
11/02/14	Cadence Pharmaceuticals, Inc. : INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. and Its Board of Directors In Connection With the Sale of the Company to Mallinckrodt plc -- CADX	PR
11/02/14	Cadence Pharmaceuticals, Inc. : CADENCE SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cadence Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Mallinckrodt plc in a Cash Deal	PR
11/02/14	Cadence Pharmaceuticals, Inc. : INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. and Its Board of Directors In Connection With the Sale of the Company to Mallinckrodt plc -- CADX	BU
11/02/14	Cadence Pharmaceuticals, Inc. : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout	BU
11/02/14	Cadence Pharmaceuticals, Inc. : Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Mallinckrodt plc	PR
11/02/14	Cadence Pharmaceuticals, Inc. : Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Cadence Pharmaceuticals Inc. and Its Board of Directors In Connection With the Sale of the Company to Mallinckrodt Plc	PR
11/02/14	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Shareholders Notice: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Proposed Sale of Cadence Pharmaceuticals, Inc. to Mallinckrodt plc	BU
13/01/14	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Estimates Fourth Quarter and Full Year 2013 Product Revenue and Provides Full Year 2014 Revenue Guidance	PR
09/12/13	Cadence Pharmaceuticals, Inc. : New Data Detailing Economic Impact of IV Acetaminophen in Treating Acute Pain to be Presented at Two Major Healthcare Conferences	PU
26/11/13	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The 25th Annual Piper Jaffray Healthcare Conference On December 4, 2013	PR
20/11/13	Cadence Pharmaceuticals, Inc. : Drug Milestones, Favorable Ruling, Official Statement, and Quarterly Report - Research Report on BioMarin, Vanda, Cadence, Prana, and Biostar	PR
15/11/13	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Positive Outcome In OFIRMEV® Patent Litigation	PR
08/11/13	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Recognized As A Top Workplace In San Diego Based On Employee Feedback	PR